Immunotherapy in endometrial cancer: rationale, practice and perspectives
Abstract Tumor immunotherapy has attracted more and more attention nowadays, and multiple clinical trials have confirmed its effect in a variety of solid tumors. Immune checkpoint inhibitors (ICIs), cancer vaccines, adoptive cell transfer (ACT), and lymphocyte-promoting cytokines are the main immuno...
Saved in:
Main Authors: | Wenyu Cao (Author), Xinyue Ma (Author), Jean Victoria Fischer (Author), Chenggong Sun (Author), Beihua Kong (Author), Qing Zhang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaginal mucositis related to immunotherapy in endometrial cancer
by: Jharna M. Patel, et al.
Published: (2021) -
Cost effectiveness of immunotherapy combination therapies for endometrial cancer
by: David J. Benjamin, et al.
Published: (2024) -
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2019) -
Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2020) -
Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma
by: He Zhang, et al.
Published: (2023)